Non-invasive continuous glucose monitoring technology
Hagar has raised €10.0M across 1 funding round from 1 investor, most recently a Series B round in Aug 2021. Based in Tel Aviv, Israel; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-12 | Series B | €10.0M |
| Columbia Pacific |
| View deal → |
